Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 7813 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 782
  1. Net price*
    Year
  2. $1,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    CardioVascular BioTherapeutics, Inc. - Product Pipeline Review - 2014

    Global Markets Direct
    27 pages
    Global Markets Direct’s, ‘CardioVascular BioTherapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the CardioVascular BioTherapeutics, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of CardioVascular BioThe
    Englisch | Zukunftsanalyse | SKU: 394125
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Cancer Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    19 pages
    Cancer Research Institute (CRI) is a cancer research institute. The institute provides immunology and cancer immunology research. It conducts clinical trials for several cancer types such as breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. The institute’s immunotherapeutic pipeline includes BioVaxID, HyperAcu
    Englisch | Zukunftsanalyse | SKU: 987672911
  4. $2,160.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Production and Market of High Fructose Corn Syrup (HFCS) in China

    Guangzhou CCM Information Science & Technology Co., Ltd.
    12 pages
    As the best substitute for sucrose, HFCS has seen a fast growth in China since 2009 due to the continuous price hike of sucrose and increasing demand. The number of new producers is increasing, and many producers have enlarged their capacity to chase the product's remarkable profit in the past five years. With the new projects of HFCS spi
    Englisch | Report | SKU: 292093
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Medical Futures Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    22 pages
    Medical Futures Inc. (Medical Futures) is a pharmaceutical company. The company develops and markets pharmaceutical and natural therapeutic products. Its products include florastor, iberogast, proferrin, pegalax, mutaflor, purfem, moviprep and onypen. Medical Futures offers products in the therapeutic areas, such as gastroenterology, pain
    Englisch | Zukunftsanalyse | SKU: 159634
  6. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    T-Cell Lymphomas – Pipeline Review, H2 2012

    Global Markets Direct
    320 pages
    Introduction Global Markets Direct’s, 'T-Cell Lymphomas - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also re
    Englisch | Pipeline Review | SKU: 317619
  7. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Prostate Cancer – Pipeline Review, H1 2013

    Global Markets Direct
    414 pages
    Introduction Global Markets Direct’s, 'Prostate Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also revi
    Englisch | Report | SKU: 318899
  8. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Dong Wha Pharma Co., Ltd. (000020) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of Dongwha Pharm Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The prof
    Englisch | Zukunftsanalyse | SKU: 85203
  9. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Thalassemia – Pipeline Review, H2 2012

    Global Markets Direct
    76 pages
    Introduction Global Markets Direct’s, 'Thalassemia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Thalassemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key
    Englisch | Report | SKU: 318259
  10. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Siena Biotech S.p.A. - Product Pipeline Review - 2013

    Global Markets Direct
    37 pages
    Global Market Direct’s pharmaceuticals report, “Siena Biotech S.p.A. - Product Pipeline Review - 2013” provides data on the Siena Biotech S.p.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This
    Englisch | Zukunftsanalyse | SKU: 386327
  11. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Hemophilia B - Pipeline Review, H1 2015

    Global Markets Direct
    106 pages
    Global Markets Direct’s, ‘Hemophilia B - Pipeline Review, H1 2015’, provides an overview of the Hemophilia B’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hemophilia B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism
    Englisch | Zukunftsanalyse | SKU: 987688331

Items 1 to 10 of 7813 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 782